Centessa Pharmaceuticals (CNTA) had its "equal weight" rating reaffirmed by Wells Fargo & Company. They now have a $42.00 price target on the stock, up from $35.00.
LowReport
Centessa Pharmaceuticals (CNTA) had its "equal weight" rating reaffirmed by Wells Fargo & Company. They now have a $42.00 price target on the stock, up from $35.00.
Centessa Pharmaceuticals (CNTA) had its "market perform" rating reaffirmed by Leerink Partners. They now have a $40.00 price target on the stock, up from $36.00.
LowReport
Centessa Pharmaceuticals (CNTA) had its "market perform" rating reaffirmed by Leerink Partners. They now have a $40.00 price target on the stock, up from $36.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: